Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs?
- 1 March 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 14 (2), 176-181
- https://doi.org/10.1097/mco.0b013e3283428df1
Abstract
Purpose of review The hypermetabolic response in critically ill patients is characterized by hyperdynamic circulatory, physiologic, catabolic and immune system responses. Failure to satisfy overwhelming energy and protein requirements after, and during critical illness, results in multiorgan dysfunction, increased susceptibility to infection, and death. Attenuation of the hypermetabolic response by various pharmacologic modalities is emerging as an essential component of the management of severe burn patients. This review focuses on the more recent advances in therapeutic strategies to attenuate the hypermetabolic response and its associated insulin resistance postburn. Recent findings At present, beta-adrenergic blockade with propranolol represents probably the most efficacious anticatabolic therapy in the treatment of burns. Other pharmacological strategies include growth hormone, insulin-like growth factor, oxandrolone and intensive insulin therapy. Summary Novel approaches to the management of critical illness by judicious glucose control and the use of pharmacologic modulators to the hypercatabolic response to critical illness have emerged. Investigation of alternative strategies, including the use of metformin, glucagon-like-peptide-1 and the PPAR-γ agonists are under current investigation.Keywords
This publication has 49 references indexed in Scilit:
- Propranolol decreases cardiac work in a dose-dependent manner in severely burned childrenSurgery, 2011
- The use of exenatide in severely burned pediatric patientsCritical Care, 2010
- Abnormal Insulin Sensitivity Persists up to Three Years in Pediatric Patients Post-BurnJournal of Clinical Endocrinology & Metabolism, 2009
- The leading causes of death after burn injury in a single pediatric burn centerCritical Care, 2009
- The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo controlled cross over studyCritical Care, 2009
- Incidence of systemic fungal infection and related mortality following severe burnsBurns, 2008
- The Effect of Oxandrolone on the Endocrinologic, Inflammatory, and Hypermetabolic Responses During the Acute Phase PostburnAnnals of Surgery, 2007
- Insulin Sensitivity and Mitochondrial Function Are Improved in Children With Burn Injury During a Randomized Controlled Trial of FenofibrateAnnals of Surgery, 2007
- The Effects of Oxandrolone and Exercise on Muscle Mass and Function in Children With Severe BurnsPediatrics, 2007
- Effects of Oxandrolone on Outcome Measures in the Severely Burned: A Multicenter Prospective Randomized Double-Blind TrialJournal of Burn Care & Research, 2006